TY - JOUR
T1 - Dramatic species differences in the susceptibility of monoamine oxidase B to a group of powerful inhibitors
AU - Krueger, Matthew J.
AU - Mazouz, Fathi
AU - Ramsay, Rona R.
AU - Milcent, René
AU - Singer, Thomas P.
PY - 1995/1/1
Y1 - 1995/1/1
N2 - Oxadiazolones and oxadiazolethiones are potent, reversible competitive inhibitors of MAO B in rat brain mitochondria. We have compared the Ki values of six of these inhibitors toward MAO B from rat, human and beef liver mitochondria, using benzylamine as substrate. Unexpectedly, their inhibitory potency varies by 3 to 4 orders of magnitude between rat and beef liver MAO B, whereas the inhibition of the rat and human liver enzymes is quite similar. Examples are 5-(4-benzyl-oxyphenyl)-3-(2-cyano-ethyl)-1,3,4- oxadiazole-2(3H)-thione, with K at 30° of 0.5 nM for rat, 0.8 nM for human, and 1,830 nM for beef liver mitochondria and 5-(4-benzyl-oxyphenyl)-3-(2-hydroxyethyl)-1,3,4- oxadiazol-2(3H)-thione, with Ki values of 1.2, 1.1 and 1,320 nM for MAO B from these three sources. Since solubilized and membrane-bound enzymes had similar sensitivities to the inhibitors, the differences seen must arise from differences in the amino acid sequences of the three enzymes.
AB - Oxadiazolones and oxadiazolethiones are potent, reversible competitive inhibitors of MAO B in rat brain mitochondria. We have compared the Ki values of six of these inhibitors toward MAO B from rat, human and beef liver mitochondria, using benzylamine as substrate. Unexpectedly, their inhibitory potency varies by 3 to 4 orders of magnitude between rat and beef liver MAO B, whereas the inhibition of the rat and human liver enzymes is quite similar. Examples are 5-(4-benzyl-oxyphenyl)-3-(2-cyano-ethyl)-1,3,4- oxadiazole-2(3H)-thione, with K at 30° of 0.5 nM for rat, 0.8 nM for human, and 1,830 nM for beef liver mitochondria and 5-(4-benzyl-oxyphenyl)-3-(2-hydroxyethyl)-1,3,4- oxadiazol-2(3H)-thione, with Ki values of 1.2, 1.1 and 1,320 nM for MAO B from these three sources. Since solubilized and membrane-bound enzymes had similar sensitivities to the inhibitors, the differences seen must arise from differences in the amino acid sequences of the three enzymes.
UR - http://www.scopus.com/inward/record.url?scp=0028928880&partnerID=8YFLogxK
U2 - 10.1006/bbrc.1995.1079
DO - 10.1006/bbrc.1995.1079
M3 - Article
AN - SCOPUS:0028928880
SN - 0006-291X
VL - 206
SP - 556
EP - 562
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -